Locally Advanced Rectal Cancer: MR Imaging in Prediction of Response after Preoperative Chemotherapy and Radiation Therapy
Authors:
- Brunella BarbaroBBBrunella Barbaro
- Cecilia FiorucciCFCecilia Fiorucci
- Carmen TebalaCTCarmen Tebala
- Vincenzo ValentiniVVVincenzo Valentini
- Maria Antonietta GambacortaMGMaria Antonietta Gambacorta
- Fabio Maria VecchioFVFabio Maria Vecchio
- Gianluca RizzoGRGianluca Rizzo
- Claudio CocoCCClaudio Coco
- Antonio CrucittiACAntonio Crucitti
- Carlo RattoCRCarlo Ratto
- Lorenzo BonomoLBLorenzo Bonomo
- 1 March 2009
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 250 (3) , 730-739
Abstract
To prospectively differentiate, at magnetic resonance (MR) imaging, patients with locally advanced nonmucinous rectal cancer who will respond to long-course chemotherapy and radiation therapy (CRT) from those who will not respond, with histopathologic results as the reference standard. Institutional review board approval for this study was obtained, and all patients provided written informed consent. High-spatial-resolution T2-weighted MR images were acquired before and 6-8 weeks after CRT in 53 patients (33 men, 20 women; mean age, 63 years; age range, 42-79 years). Patients were categorized as responders to CRT (patients with T3 cancer that converted to T2 or a lower stage, patients with T4 cancer that converted to T3 or a lower stage) or as nonresponders (patients with stable or progressive disease). At the posttreatment MR imaging examination, a decrease in signal intensity was considered to represent a morphologic response with fibrosis. Before CRT and surgery, tumor volume was calculated at MR imaging by multiplying cross-sectional area by section thickness. Tumor length was measured at MR imaging and in the histopathologic specimen. Nodal downstaging was evaluated. The relationship between pathologic response, morphologic MR imaging response, and percentage volume reduction was evaluated with the Mann-Whitney-Wilcoxon two-sample test. Morphologic response assessment with MR imaging achieved a positive predictive value (PPV) of 84.2% (32 of 38) and a negative predictive value (NPV) of 66.7% (10 of 15). Volume reduction extent (> or = 70%) was significantly different between patients in whom disease was downstaged and those in whom it was not downstaged (P = .000005) and showed additional diagnostic value, with an overall accuracy of 86.8% (46 of 53). Presurgical MR imaging and histopathologic tumor length did not show a significant difference. MR imaging accuracy for lymph node (N) stage was 86.8% (46 of 53) on the basis of morphologic criteria. After CRT, morphologic and volumetric evaluation at MR imaging had a high PPV and a low NPV for response assessment. The detection of small clusters of residual tumor cells within fibrosis remains a problem. http://radiology.rsnajnls.org/cgi/content/full/250/3/730/DC1.Keywords
This publication has 40 references indexed in Scilit:
- Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Journal of Clinical Oncology, 2006
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancerBritish Journal of Surgery, 2006
- Chemotherapy with Preoperative Radiotherapy in Rectal CancerNew England Journal of Medicine, 2006
- The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Colorectal cancer screening: Clinical guidelines and rationaleGastroenterology, 1997